Top Markets
Coin of the day
Kidswell Bio Corporation Kidswell Bio Corporation

Kidswell Bio Corporation

4584
Xếp hạng trong cổ phiếu #24964
Kidswell Bio Corporation, headquartered in Tokyo, Japan, specializes in the... Kidswell Bio Corporation, headquartered in Tokyo, Japan, specializes in the development of pharmaceutical treatments for rare and complex diseases. The company, which was founded in 2001 and operated as Gene Techno Science Co.,Ltd. until rebranding in July 2021, maintains a robust pipeline of therapeutic candidates. This includes GND-004, designed for both ophthalmic conditions and oncology, and GND-007, aimed at immunological disorders. Their portfolio also features a range of antibodies being developed for cancer therapies. Further expanding its research, the GBS series encompasses GBS-001, GBS-004, and GBS-010 for oncology; GBS-005 for immunological diseases; GBS-007 and GBS-012 for eye-related ailments; GBS-008 for infectious diseases; and GBS-011 for renal conditions. Additionally, Kidswell Bio is progressing GCT-101 for alveolar clefts, GCT-102 for congenital isolated hypoganglionosis, alongside other investigational products addressing ophthalmologic disorders, cerebral palsy, peripheral nerve palsy, fractures, and spinal cord injuries.
Giá cổ phiếu
$1.11
Vốn hóa thị trường
$55.05M
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
-36.23%
Quốc gia
JP
Giao dịch Kidswell Bio Corporation (4584)

Danh mục

Lịch sử giá cổ phiếu của Kidswell Bio Corporation (4584)
Giá đóng cửa cao nhất: $1.05 vào 2026-08-01

Giá đóng cửa thấp nhất: $4.24 vào 2012-11-01
Lịch sử giá cổ phiếu của Kidswell Bio Corporation từ 2012 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) 6.26%
2025 85.15%
2024 -18.76%
2023 -55.53%
2022 -51.13%
2021 -14.74%
2020 -45.17%
2019 17.42%
2018 -35.72%
2017 71.03%
2016 51.70%
2015 11.50%
2014 -41.27%
2013 43.55%
2012 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$759.53 8.32%
CH
$130.43 397.46%
US